A phase 2 evaluation of combined mitomycin C (M), vincristine (V), Cis-platinum (P) (MVP) in advanced nonsmall cell lung cancer (NSCLC)

Y. C.A. Chang, P. J. Kuebler, D. C. Tormey

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 evaluation of combined mitomycin C (M), vincristine (V), Cis-platinum (P) (MVP) in advanced nonsmall cell lung cancer (NSCLC)'. Together they form a unique fingerprint.